A carregar...

Bisphosphonate Use After Estrogen Receptor–Positive Breast Cancer and Risk of Contralateral Breast Cancer

BACKGROUND: A growing body of evidence suggests that nitrogenous bisphosphonates may reduce the risk of developing a first breast cancer and may prevent metastases among breast cancer survivors. However, their impact on risk of second primary contralateral breast cancer is uncertain. METHODS: Within...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Monsees, Genevieve M., Malone, Kathleen E., Tang, Mei-Tzu C., Newcomb, Polly A., Li, Christopher I.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232186/
https://ncbi.nlm.nih.gov/pubmed/22021667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!